SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCI...(General and administrative ...)

Date:8/4/2009

General and administrative (including $1,049, $1,069, $2,061 and $2,079, respectively, of non-cash stock-based compensation) 3,191 3,435 6,470 6,718 ----- ----- ----- ----- Total operating expenses 11,035 11,552 21,900 23,004 Loss from operations (8,069) (7,986) (15,422) (13,369) Interest income 22 309 34 869 --- --- --- --- Net loss $(8,047) $(7,677) $(15,388) $(12,500) ======== ======== ========= ========= Basic and diluted net loss per share $(0.26) $(0.25) $(0.50) $(0.41) ======= ======= ======= ======= Weighted average shares used in computing basic and diluted net loss per share 30,918 30,588 30,840 30,561 ====== ====== ====== ======

                      Condensed Balance Sheets
                           (in thousands)

                                       June 30,     December 31,
                                         2009           2008
                                         ----           ----
                                      (unaudited)

      Cash, cash equivalents and
       investments
       available-for-sale               $27,562       $40,106
      Other current assets                  815           942
      Property and equipment, net        12,083        13,418
                                         ------        ------
        Total assets                    $40,460       $54,466
 
'/>"/>
SOURCE  Senomyx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 
Related biology technology :

1. Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc.
2. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC
3. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
6. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
7. SENOMYX, INC. THIRD QUARTER 2008 EARNINGS CONFERENCE CALL SCHEDULED FOR NOVEMBER 6, 2008
8. SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY
9. SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
10. SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER SUCRALOSE
11. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE